Current and historical daily PE Ratio for Basilea Pharmaceutica Ltd (
) from 2004 to May 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Basilea Pharmaceutica stock (XSWX:BSLN) PE ratio as of May 24 2024 is 70.09.
More Details
Basilea Pharmaceutica Ltd (XSWX:BSLN) PE Ratio (TTM) Chart
Basilea Pharmaceutica Ltd (XSWX:BSLN) PE Ratio (TTM) Historical Data
View and export this data going back to 2004. Start your Free Trial
Total 1269
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Basilea Pharmaceutica PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-24 | 70.1 | 2024-03-15 | 56.5 |
| 2024-05-23 | 70.1 | 2024-03-14 | 57.2 |
| 2024-05-22 | 68.7 | 2024-03-13 | 57.0 |
| 2024-05-21 | 68.4 | 2024-03-12 | 60.2 |
| 2024-05-17 | 69.3 | 2024-03-11 | 60.7 |
| 2024-05-16 | 70.3 | 2024-03-08 | 60.4 |
| 2024-05-15 | 69.7 | 2024-03-07 | 59.8 |
| 2024-05-14 | 70.6 | 2024-03-06 | 58.9 |
| 2024-05-13 | 68.4 | 2024-03-05 | 58.3 |
| 2024-05-10 | 68.2 | 2024-03-04 | 56.6 |
| 2024-05-08 | 68.0 | 2024-03-01 | 55.8 |
| 2024-05-07 | 64.6 | 2024-02-29 | 55.8 |
| 2024-05-06 | 63.8 | 2024-02-28 | 57.0 |
| 2024-05-03 | 63.3 | 2024-02-27 | 57.1 |
| 2024-05-02 | 62.9 | 2024-02-26 | 57.5 |
| 2024-04-30 | 62.7 | 2024-02-23 | 57.5 |
| 2024-04-29 | 63.8 | 2024-02-22 | 58.4 |
| 2024-04-26 | 64.0 | 2024-02-21 | 57.6 |
| 2024-04-25 | 63.9 | 2024-02-20 | 59.0 |
| 2024-04-24 | 64.4 | 2024-02-19 | 59.3 |
| 2024-04-23 | 65.5 | 2024-02-16 | 58.6 |
| 2024-04-22 | 64.9 | 2024-02-15 | 59.4 |
| 2024-04-19 | 64.7 | 2024-02-14 | 59.0 |
| 2024-04-18 | 66.6 | 2024-02-13 | 57.9 |
| 2024-04-17 | 66.2 | 2024-02-12 | 53.3 |
| 2024-04-16 | 65.2 | 2024-02-09 | 51.5 |
| 2024-04-15 | 64.6 | 2024-02-08 | 51.2 |
| 2024-04-12 | 64.2 | 2024-02-07 | 51.4 |
| 2024-04-11 | 64.4 | 2024-02-06 | 52.8 |
| 2024-04-10 | 64.9 | 2024-02-05 | 51.8 |
| 2024-04-09 | 65.2 | 2024-02-02 | 51.8 |
| 2024-04-08 | 65.5 | 2024-02-01 | 52.5 |
| 2024-04-05 | 67.8 | 2024-01-31 | 53.8 |
| 2024-04-04 | 68.5 | 2024-01-30 | 54.0 |
| 2024-04-03 | 61.0 | 2024-01-29 | 53.9 |
| 2024-04-02 | 59.1 | 2024-01-26 | 54.8 |
| 2024-03-28 | 59.8 | 2024-01-25 | 53.6 |
| 2024-03-27 | 59.9 | 2024-01-24 | 55.5 |
| 2024-03-26 | 59.5 | 2024-01-23 | 53.6 |
| 2024-03-25 | 58.6 | 2024-01-22 | 53.2 |
| 2024-03-22 | 58.5 | 2024-01-19 | 53.9 |
| 2024-03-21 | 56.5 | 2024-01-18 | 52.5 |
| 2024-03-20 | 55.1 | 2024-01-17 | 52.1 |
| 2024-03-19 | 55.8 | 2024-01-16 | 54.3 |
| 2024-03-18 | 55.6 | 2024-01-15 | 55.0 |
Basilea Pharmaceutica Ltd (XSWX:BSLN) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Basilea Pharmaceutica Ltd
ISIN : CH0011432447
Compare
Compare
Traded in other countries / regions
BSLN.Switzerland0QNA.UKBPMUF.USAPK5.Germany IPO Date
2004-03-25Description
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers